Literature DB >> 16703327

Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.

P Tessari1, E Kiwanuka, R Barazzoni, M Vettore, M Zanetti.   

Abstract

AIMS/HYPOTHESIS: Hyperfibrinogenaemia and albuminuria are cardiovascular risk factors, often coexisting in diabetic and non-diabetic people. Albuminuria in turn is associated with a compensatory albumin overproduction in non-diabetic patients. It is not known whether the presence of albuminuria in patients with type 2 diabetes mellitus is associated with greater albumin and fibrinogen production rates than in normoalbuminuric patients. SUBJECTS, MATERIALS, AND METHODS: Using leucine isotope methods, we measured fractional and absolute synthesis rates (FSR, ASR) of albumin and fibrinogen in post-absorptive type 2 diabetic patients with either normal (n=11) or increased (n=10) urinary albumin excretion.
RESULTS: In albuminuric patients, albumin FSR (16.2+/-1.5%/day) and ASR (20.5+/-1.9 g/day) were greater (p<0.02 and p<0.05, respectively) than in normoalbuminuric patients (FSR=11.5+/-1.1%/day; ASR=15.7+/-1.2 g/day). Fibrinogen FSR was similar between patients with normal and increased albumin excretion, but concentration, the circulating pool and ASR of fibrinogen were 40 to 50% greater (p<0.035) in patients with albuminuria. Albuminuria was positively correlated with albumin ASR, with fibrinogen concentration, the fibrinogen pool and ASR, whereas albumin synthesis was inversely correlated with calculated oncotic pressure. CONCLUSIONS/
INTERPRETATION: Synthesis of albumin and fibrinogen is upregulated in type 2 diabetic patients with increased urinary albumin excretion. Albuminuria is associated with enhanced fibrinogen and albumin synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703327     DOI: 10.1007/s00125-006-0288-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents.

Authors:  Prabhakaran Balagopal; Shawn Sweeten; Nelly Mauras
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

2.  Erythrocyte sedimentation rate in glomerular disease: association with urinary protein.

Authors:  P C Liverman; F L Tucker; W K Bolton
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

3.  Plasma protein synthesis in patients with low-grade nephrotic proteinuria.

Authors:  M Zanetti; R Barazzoni; G Garibotto; G Davanzo; C Gabelli; E Kiwanuka; A Piccoli; M Tosolini; P Tessari
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-04       Impact factor: 4.310

4.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

Authors:  M I Schmidt; B B Duncan; A R Sharrett; G Lindberg; P J Savage; S Offenbacher; M I Azambuja; R P Tracy; G Heiss
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

5.  Hyperfibrinogenemia in patients of diabetes mellitus in relation to glycemic control and urinary albumin excretion rate.

Authors:  A Jain; H L Gupta; S Narayan
Journal:  J Assoc Physicians India       Date:  2001-02

6.  Determination of plasma volume with indocyanine green in man.

Authors:  M Haller; C Akbulut; H Brechtelsbauer; W Fett; J Briegel; U Finsterer; K Peter
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

7.  Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans.

Authors:  P De Feo; M G Gaisano; M W Haymond
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.

Authors:  R Fogari; A Zoppi; P Lazzari; P Preti; A Mugellini; L Corradi; P Lusardi
Journal:  J Cardiovasc Pharmacol       Date:  1998-10       Impact factor: 3.105

Review 9.  Microalbuminuria. Implications for micro- and macrovascular disease.

Authors:  T Deckert; A Kofoed-Enevoldsen; K Nørgaard; K Borch-Johnsen; B Feldt-Rasmussen; T Jensen
Journal:  Diabetes Care       Date:  1992-09       Impact factor: 19.112

10.  Haemostatic variables associated with diabetes and its complications.

Authors:  J H Fuller; H Keen; R J Jarrett; T Omer; T W Meade; R Chakrabarti; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-10-20
View more
  10 in total

1.  Factors associated with diabetic nephropathy in subjects with proliferative retinopathy.

Authors:  Caroline Jane Magri; Neville Calleja; Gerald Buhagiar; Stephen Fava; Josanne Vassallo
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

2.  Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.

Authors:  Lianlian Pan; Mingyi Wo; Chan Xu; Yan Wu; Yali Ye; Fan Han; Xianming Fei; Fengjiao Zhu
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Increased serum kallistatin levels in type 1 diabetes patients with vascular complications.

Authors:  Alicia J Jenkins; Jeffrey D McBride; Andrzej S Januszewski; Connie S Karschimkus; Bin Zhang; David N O'Neal; Craig L Nelson; Jasmine S Chung; C Alex Harper; Timothy J Lyons; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-09-22

4.  Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients.

Authors:  M Giordano; P Lucidi; T Ciarambino; L Gesuè; P Castellino; M Cioffi; P Gresele; G Paolisso; P De Feo
Journal:  Diabetologia       Date:  2007-11-17       Impact factor: 10.122

5.  Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.

Authors:  Sheng-Hua Yang; Ying Du; Yan Zhang; Xiao-Lin Li; Sha Li; Rui-Xia Xu; Cheng-Gang Zhu; Yuan-Lin Guo; Na-Qiong Wu; Ping Qing; Ying Gao; Chuan-Jue Cui; Qian Dong; Jing Sun; Jian-Jun Li
Journal:  BMJ Open       Date:  2017-06-09       Impact factor: 2.692

6.  Fibrinogen to Albumin Ratio as an Independent Risk Factor for Type 2 Diabetic Kidney Disease.

Authors:  Kai Wang; Wenjun Xu; Bingbing Zha; Jindong Shi; Guowei Wu; Heyuan Ding
Journal:  Diabetes Metab Syndr Obes       Date:  2021-11-15       Impact factor: 3.168

7.  Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients.

Authors:  Jing Yang; Dongwei Liu; Zhangsuo Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-25       Impact factor: 5.555

8.  Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?

Authors:  Shereen Morsy; Mona F Mansour; Mohamed Abdo; Yasser El-Wazir
Journal:  Physiol Rep       Date:  2022-09

9.  Bioinformatics Analysis Reveals Crosstalk Among Platelets, Immune Cells, and the Glomerulus That May Play an Important Role in the Development of Diabetic Nephropathy.

Authors:  Xinyue Yao; Hong Shen; Fukai Cao; Hailan He; Boyu Li; Haojun Zhang; Xinduo Zhang; Zhiguo Li
Journal:  Front Med (Lausanne)       Date:  2021-06-24

Review 10.  Dicarbonyl stress in clinical obesity.

Authors:  Jinit Masania; Malgorzata Malczewska-Malec; Urszula Razny; Joanna Goralska; Anna Zdzienicka; Beata Kiec-Wilk; Anna Gruca; Julita Stancel-Mozwillo; Aldona Dembinska-Kiec; Naila Rabbani; Paul J Thornalley
Journal:  Glycoconj J       Date:  2016-06-24       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.